Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by themagicboxon Feb 14, 2020 6:11pm

122 Views

Post# 30694028

RE:RE:RE:RE:RE:RE:If no FE announcement by Sunday

lol I never said the story ever changed (hence why I am long) and that FE wont happen, just a delay. And we'll see if I'm wrong. ATE never misses an opportunity to miss an deadline.

Mid sept eh, well you are free to post all of my posts where I have been wrong and tackle the points I have made one by one. Ball (and tea leaves) are your court...Go highlight what I said and address it. Otherwise, you're denying the obvious looming drop in SP that will happen. Will dip below 60.

My opinions are clearly getting under your skin haha

qwerty22 wrote:
You're an odd fellow, it's worse that I thought. I had a quick look at your history. You've been calling this stock down since mid-Sept last year and yet you say your a long term backer of ATE. That's when it was in the 30's. Your ability to ignore reality is astounding. To be endlessly wrong yet still stick with your "hypotheses" is truly amazing. (Btw you're giving that word a bad name.)

If you back your hypotheses with evidence then do you ever change your hypotheses on evidence? The evidence is you've been wrong, then wrong, then wrong again about the SP. it's possible where you are looking for evidence is the wrong place to look. The evidence has been so far these delays have not been driving the SP. For the most part they've been short term hiccups. The market knows FE will happen, no need to sweat over that detail. It's the outcome of the trial that matters, the potential upside from a good data readout, and downside if you believe in a negative outcome.

I think your problem is you're reading the wrong tea leaves.

(it's binomial btw and you're almost certainly misusing it.)

themagicbox wrote: I suppose people read what they want to read.

1- No have definitely not sold my ALL my shares. Been with ATE since the .08c purchases. So im greener than weed.
2-Nothing wrong with taking some profit. which I have done. Thats called smart investing.
3-by me actually informing people how binomal biotech behave they make better decisions and are likely to revisit i.e. stay long, with the stock, rather than play it as a pump and dump
4- I have always backed my hypotheses with evidence. Even when discussing the clinics I posted the which clinics and the numbers so others can verify.
5- Given the way you asked the question, I will buy back in when I do....I dont present pearls before swine.

Kipawarocks15 wrote: So it's safe to say that you have sold all of your ATE holdings based on the impending pullback. Why are you still here with the "die hards...dopes...unrealistic dreamers ...and investing rubes"? At what point are you going to buy back in ?